SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-007801
Filing Date
2018-06-18
Accepted
2018-06-18 16:41:42
Documents
4
Period of Report
2018-06-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k061418_immucellcorp.htm 8-K 41670
2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF IMMUCELL CORPORATION f8k061418ex3-1_immucellcorp.htm EX-3.1 20368
3 GRAPHIC ex3-1_001.jpg GRAPHIC 19980
4 GRAPHIC ex3-1_002.jpg GRAPHIC 15098
  Complete submission text file 0001213900-18-007801.txt   111812
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 18905130
SIC: 2835 In Vitro & In Vivo Diagnostic Substances